SMAD4 and non-small cell lung carcinoma: To the best of our knowledge, no studies have investigated potential associations between single nucleotide polymorphisms (SNPs) in hepcidin regulatory BMP/Smad4/Hamp signaling pathways and outcomes (disease control and survival) among patients with NSCLC receiving definitive radiotherapy.